Ser196
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser196  -  CTNNB1 (human)

Site Information
MRsPQMVsAIVRTMQ   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3653233

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 2 , 3 )
Disease tissue studied:
breast cancer ( 3 ) , lung cancer ( 2 ) , non-small cell lung cancer ( 2 )
Relevant cell line - cell type - tissue:
H2009 (pulmonary) ( 2 ) , H2077 (pulmonary) ( 2 ) , H2887 (pulmonary) ( 2 ) , H322 (pulmonary) ( 2 ) , H322M (pulmonary) ( 2 ) , HOP62 (pulmonary) ( 2 ) , MCF10A1 (epithelial) ( 3 ) , MCF10AT1K (epithelial) ( 3 ) , MCF10CA1a (epithelial) ( 3 ) , MCF10CA1h (epithelial) ( 3 )

References 

1

Shiromizu T, et al. (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12, 2414-21
23312004   Curated Info

2

Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68
22617229   Curated Info

3

Chen Y, et al. (2007) Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics 6, 2072-87
17855441   Curated Info